Entrada Therapeutics (TRDA) Other Working Capital Changes (2022 - 2026)
Entrada Therapeutics (TRDA) posted quarterly Other Working Capital Changes of -$1.2 million for Q1 2026, up 46.52% year-over-year from -$806738.7 in Q1 2025, and up 19.48% quarter-over-quarter from -$1.5 million in Q4 2025.
Entrada Therapeutics (TRDA) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Entrada Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$1.2 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 46.52% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$7.2 million (up 23.19% YoY), while the FY2025 annual figure was -$8.3 million, up 8.29% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.2 million, up from -$1.5 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $211.6 million in Q1 2023, with the low at -$222.5 million in Q2 2023.
- The 5-year median for Other Working Capital Changes is $2.5 million (2026), against an average of $1.9 million.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes jumped 141.76% in 2023, then plunged 350.54% in 2024.
- Entrada Therapeutics' Other Working Capital Changes stood at -$2.0 million in 2022, then surged by 141.76% to $841000.0 in 2023, then slumped by 350.54% to -$2.1 million in 2024, then soared by 30.33% to -$1.5 million in 2025, then increased by 19.48% to -$1.2 million in 2026.
- Business Quant data shows TRDA's Other Working Capital Changes at -$1.2 million in Q1 2026, -$1.5 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Entrada Therapeutics | 290.47 Mn | 290.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.21 Mn |
| Jun 30, 2026 | -1.21 Mn |
| Jun 30, 2026 | -1.21 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Dec 31, 2025 | -1.47 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Jun 30, 2025 | -2.25 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Mar 31, 2025 | -2.21 Mn |
| Dec 31, 2024 | -2.11 Mn |
| Dec 31, 2024 | -2.11 Mn |